Amber Implants VCFix® spinal system receives US FDA Breakthrough Designation
The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces its VCFix® spinal system, which aims to improve the treatment of vertebral fractures, has been granted the Breakthrough Device Designation by the US FDA.
